Research progress on internal classification and treatment response of chronic rhinosinusitis
-
Abstract: Chronic rhinosinusitis(CRS) is one of the common upper airway disease, which is complex and heterogenerous.It is known that based on clinical observations, CRS phenotype has been classified into CRSwNP and CRSsNP.However, there is still not any uniform standard to differentiate CRS endotype.According to CRS phenotype. The clinical effect of CRS treatment is not satisfied, including bad effects an high reccurence rate because of unclear mechanism.Therefore, it is important to explore CRS endotype, which could help us to recognize the pathologicalmechanism of the disease and to obtain optimal therapies, in order to improve health quality and relieve social burdern.
-
Key words:
- chronic rhinosinusitis /
- endotype /
- therapy
-
-
[1] Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists[J]. Rhinology, 2012, 50(1): 1-12. doi: 10.4193/Rhino12.000
[2] Fokkens W, Lund V, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2007[J]. Rhinol Suppl, 2007, 20: 1-136.
[3] Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline(update): Adult Sinusitis Executive Summary[J]. Otolaryngol Head Neck Surg, 2015, 152(4): 598-609. doi: 10.1177/0194599815574247
[4] Shi JB, Fu QL, Zhang H, et al. Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities[J]. Allergy, 2015, 70(5): 533-539. doi: 10.1111/all.12577
[5] Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches[J]. Nat Med, 2012, 18(5): 716-725. doi: 10.1038/nm.2678
[6] Bachert C. Innovative therapeutic targets in chronic sinusitis with nasal polyps[J]. Braz J Otorhinolaryngol, 2016, 82(3): 251-252. doi: 10.1016/j.bjorl.2016.03.001
[7] Bachert C, Gevaert P, Hellings P. Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps[J]. J Allergy Clin Immunol Pract, 2017, 5(6): 1512-1516. doi: 10.1016/j.jaip.2017.04.024
[8] Kim DW, Cho SH. Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine[J]. Allergy Asthma Immunol Res, 2017, 9(4): 299-306. doi: 10.4168/aair.2017.9.4.299
[9] Bachert C, Zhang N, Hellings PW, et al. Endotype-driven care pathways in patients with chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2018, 141(5): 1543-1551. doi: 10.1016/j.jaci.2018.03.004
[10] Alsharif S, Jonstam K, van Zele T, et al. Endoscopic Sinus Surgery for Type-2 CRS wNP: An Endotype-Based Retrospective Study[J]. Laryngoscope, 2019, 129(6): 1286-1292. doi: 10.1002/lary.27815
[11] Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease[J]. Lancet, 2008, 372(9643): 1107-1119. doi: 10.1016/S0140-6736(08)61452-X
[12] Van Zele T, Holtappels G, Gevaert P, et al. Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps[J]. Am J Rhinol Allergy, 2014, 28(3): 192-198. doi: 10.2500/ajra.2014.28.4033
[13] Bachert C, Zhang N, van Zele T, et al. Chronic rhinosinusitis: from one disease to different phenotypes. Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology, 2012, 23(Suppl 22): 2-4.
[14] Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers[J]. J Allergy Clin Immunol, 2016, 137(5): 1449-1456. e4. doi: 10.1016/j.jaci.2015.12.1324
[15] Jonstam K, Westman M, Holtappels G, et al. Serum periostin, IgE, and SE-IgE can be used as biomarkers to identify moderate to severe chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2017, 140(6): 1705-1708. e3. doi: 10.1016/j.jaci.2017.07.031
[16] Maxfield AZ, Landegger LD, Brook CD, et al. Periostin as a Biomarker for Nasal Polyps in Chronic Rhinosinusitis[J]. Otolaryngol Head Neck Surg, 2018, 158(1): 181-186. doi: 10.1177/0194599817737967
[17] Liao B, Liu JX, Li ZY, et al. Multidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes[J]. Allergy, 2018, 73(7): 1459-1469. doi: 10.1111/all.13411
[18] Stewart AE, Hunsaker DH. Fungus-specific IgG and IgE in allergic fungal rhinosinusitis[J]. Otolaryngol Head Neck Surg, 2002, 127(4): 324-332. doi: 10.1067/mhn.2002.126801
[19] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 慢性鼻-鼻窦炎诊断和治疗指南(2012年, 昆明)[J]. 中华耳鼻咽喉头颈外科杂志, 2013, 48(2): 92-94. doi: 10.3760/cma.j.issn.1673-0860.2013.02.002
[20] Orlandi RR, Kingdom TT, Hwang PH, Smith TL, Alt JA, Baroody FM, et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. International forum of allergy & rhinology 2016, 6(Suppl 1): S22-209.
[21] Bachert C, Mannent L, Naclerio RM, et al. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial[J]. JAMA, 2016, 315(5): 469-479. doi: 10.1001/jama.2015.19330
[22] Bachert C, Hellings PW, Mullol J, et al. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis[J]. Allergy, 2020, 75(1): 148-157. doi: 10.1111/all.13984
[23] Lund VJ, Kennedy DW. Quantification for staging sinusitis. The Staging and Therapy Group[J]. Ann Otol Rhinol Laryngol Suppl, 1995, 167: 17-21.
[24] Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1997, 117(3 Pt 2): S35-40.
[25] 张罗. 展望慢性鼻-鼻窦炎伴鼻息肉的精准治疗[J]. 中华耳鼻咽喉头颈外科杂志, 2017, 52(2): 81-84. doi: 10.3760/cma.j.issn.1673-0860.2017.02.001
[26] Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012 Mar; 23: 3 p preceding table of contents, 1-298.
[27] Baguley C, Brownlow A, Yeung K, et al. The fate of chronic rhinosinusitis sufferers after maximal medical therapy[J]. Int Forum Allergy Rhinol, 2014, 4(7): 525-532. doi: 10.1002/alr.21315
[28] Gevaert P, Lang-Loidolt D, Lackner A, et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps[J]. J Allergy Clin Immunol, 2006, 118(5): 1133-1141. doi: 10.1016/j.jaci.2006.05.031
[29] Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma[J]. J Allergy Clin Immunol, 2013, 131(1): 110-116. e1. doi: 10.1016/j.jaci.2012.07.047
[30] Pinto JM, Mehta N, DiTineo M, et al. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis[J]. Rhinology, 2010, 48(3): 318-324. doi: 10.4193/Rhino09.144
[31] Lou H, Meng Y, Piao Y, et al. Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population[J]. Am J Rhinol Allergy, 2015, 29(5): 350-356. doi: 10.2500/ajra.2015.29.4231
[32] Adnane C, Adouly T, Khallouk A, et al. Using preoperative unsupervised cluster analysis of chronic rhinosinusitis to inform patient decision and endoscopic sinus surgery outcome[J]. Eur Arch Otorhinolaryngol, 2017, 274(2): 879-885. doi: 10.1007/s00405-016-4315-8
[33] Lou H, Meng Y, Piao Y, et al. Cellular phenotyping of chronic rhinosinusitis with nasal polyps[J]. Rhinology, 2016, 54(2): 150-159. doi: 10.4193/Rhino15.271
[34] Akdis CA, Bachert C, Cingi C, et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology[J]. J Allergy Clin Immunol, 2013, 131(6): 1479-1490. doi: 10.1016/j.jaci.2013.02.036
[35] Nakayama T, Asaka D, Kanaya H, et al. Prognostic factors for recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps[J]. Auris Nasus Larynx, 2016, 43(6): 641-647. doi: 10.1016/j.anl.2016.02.015
-
计量
- 文章访问数: 2029
- PDF下载数: 407
- 施引文献: 0
下载: